CRWV insider sells: 50,000 shares via Rule 144; recent 10b5-1 transactions disclosed

Rhea-AI Filing Summary

Form 144 notice for CoreWeave, Inc. (CRWV): The filing reports a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $6,544,500, scheduled for 09/24/2025 on NASDAQ. The shares were acquired as founders' shares on 11/13/2017. The filing also lists recent 10b5-1 sales: two sales on 09/10/2025 and two on 08/27/2025, by Michael Intrator and Omnadora Capital LLC, with gross proceeds shown for each transaction. The notice includes the standard representation that the seller knows of no undisclosed material adverse information.

Positive

• Disclosure compliance: The filer provides required Rule 144 details including broker, class, acquisition date, and planned sale date.
• Use of 10b5-1 plans: Recent sales are identified as 10b5-1 transactions, indicating prearranged trading plans for orderly dispositions.

Negative

• Insider liquidity: Multiple sales by insiders/related parties totaling material gross proceeds may be perceived as increased insider selling pressure.
• Materiality of proposed sale: The planned 50,000-share sale valued at $6,544,500 is sizable and could be notable relative to public float.

Insights

Securities Analyst

TL;DR: Insider-related sales and a planned 50,000-share Rule 144 disposal worth $6.54M are disclosed; transactions appear executed under 10b5-1 plans.

The filing documents a proposed Rule 144 sale of 50,000 founder shares acquired in 2017, routed through Morgan Stanley Smith Barney with an indicated market value of $6,544,500. The record of recent 10b5-1 sales on 08/27/2025 and 09/10/2025 for Michael Intrator and Omnadora Capital LLC shows multiple dispositions and material gross proceeds. For investors, the filing is a routine disclosure of insider liquidity and compliance with resale rules; it does not include company operational or financial data.

Corporate Governance Expert

TL;DR: This is a standard insider resale notice showing adherence to Rule 144 and use of 10b5-1 plans, signaling permitted insider liquidity.

The notice specifies the class, broker, acquisition date, and that shares were founders' shares from 2017. Multiple recent 10b5-1 sales by identified sellers are listed with gross proceeds, and the filer affirms no undisclosed material adverse information. The disclosure aligns with regulatory requirements; it provides transparency on insider selling but contains no governance changes or allegations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	6544500.00	370470348	09/24/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			50000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/10/2025	32455	3840276.82
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/10/2025	50000	5916310.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/27/2025	32455	3104307.77
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/27/2025	50000	4782480.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CoreWeave (CRWV) disclose?

The Form 144 discloses a proposed sale of 50,000 common shares valued at $6,544,500, scheduled for 09/24/2025, and recent 10b5-1 sales on 08/27/2025 and 09/10/2025.

Who conducted recent sales listed in the filing?

The filing lists 10b5-1 sales by Michael Intrator and Omnadora Capital LLC, with addresses shown in the notice.

When were the shares to be sold originally acquired?

The 50,000 shares to be sold were acquired as founders' shares on 11/13/2017.

Through which broker will the proposed sale occur?

The proposed sale is through Morgan Stanley Smith Barney LLC, Executive Financial Services on the NASDAQ exchange.

Does the filing state whether undisclosed material information exists?

The signer represents that they do not know any material adverse information regarding the issuer that has not been publicly disclosed.